WHO ICTRP trial
Observe the therapeutic effect of 3% dexamethasone eye drops on chemical eye…
ChiCTR2200064663 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200064663 |
|---|---|
| Public title | Observe the therapeutic effect of 3% dexamethasone eye drops on chemical eye injury based on goblet cell and ocular surface mucin levels |
| Scientific title | Observe the therapeutic effect of 3% dexamethasone eye drops on chemical eye injury based on goblet cell and ocular surface mucin levels |
| Primary sponsor | Wuhan Aier Ophthalmology Hanyang Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | ocular chemical burns |
| Interventions | Treatment group:Dexamethoxol sodium 0.3% eye drops were added to routine treatment;Control group:Routine treatment |
| Registration date | Oct 13, 2022 |
| Target size | Treatment group:20;Control group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: